Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.790
-0.100 (-3.46%)
At close: Nov 18, 2025, 4:00 PM EST
2.790
0.00 (0.00%)
After-hours: Nov 18, 2025, 5:27 PM EST
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $5.22 million as of November 18, 2025. Its market cap has increased by 352.06% in one year.
Market Cap
5.22M
Enterprise Value
-960.82K
1-Year Change
352.06%
Ranking
Category
Stock Price
$2.79
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $5.22M, a decrease of -98.39%. That is a compound annual growth rate of -64.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 5.41M | -42.08% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
| Dec 10, 2021 | 323.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |